Pure Global AI
UMIN000049280Recruitment Completed

Survey of the data needs for endpoints on side effects of drug therapy in breast cancer patients.

Daiichi Sankyo Co., LtdNot ApplicableUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
Disease/Condition
Breast cancer
Study type
Observational
Sponsor & location
Primary sponsor
Daiichi Sankyo Co., Ltd
Location
Japan
Timeline & enrollment
Phase
Not Applicable
Start date
Oct 31, 2022
End date
N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000049280
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for UMIN000049280 through Pure Global AI's free database. This Not Applicable trial is sponsored by Daiichi Sankyo Co., Ltd and is currently Recruitment Completed. The study focuses on Breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.